This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Personal Genome Diagnostics, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Gustavo Cerqueira: Innovator in Cancer Treatment Prediction
Introduction
Gustavo Cerqueira is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. His work focuses on improving the prediction of responses for cancer patients treated with immunotherapy.
Latest Patents
Gustavo Cerqueira holds a patent for a method that enhances the prediction of therapeutic responses in cancer patients. The patent, titled "Method of improving prediction of response for cancer patients treated with immunotherapy," outlines a process for determining a therapeutic regimen based on tumor mutation burden (TMB) and loss of heterozygosity (LOH). This method indicates that high TMB combined with no LOH suggests a positive outcome when treated with a checkpoint inhibitor, while high TMB with LOH indicates a poor outcome.
Career Highlights
Gustavo Cerqueira is associated with Personal Genome Diagnostics, Inc., where he applies his expertise in genomics and cancer research. His innovative approach has the potential to significantly impact treatment strategies for cancer patients, leading to more personalized and effective therapies.
Collaborations
Gustavo collaborates with Nicholas C Dracopoli, a fellow researcher in the field. Their combined efforts aim to advance the understanding of cancer treatment and improve patient outcomes.
Conclusion
Gustavo Cerqueira's work exemplifies the intersection of innovation and healthcare, particularly in the realm of cancer treatment. His patented method represents a significant advancement in predicting patient responses to immunotherapy, showcasing the importance of research in improving medical outcomes.